India Initiates Anti-Dumping Investigation on Chinese Ethyl Chloroformate
India has formally launched an anti-dumping investigation into imports of ethyl chloroformate from China. This decisive action follows a detailed complaint filed by domestic chemical producer Paushak Limited, which alleges that Chinese exporters are selling the chemical in the Indian market at unfairly low prices, causing significant harm to the local industry.
DGTR Begins Probe After Paushak's Complaint
The Directorate General of Trade Remedies (DGTR), operating under the Union Ministry of Commerce and Industry, has commenced the investigation. This move was triggered by a formal application submitted by Paushak, India's sole domestic manufacturer of ethyl chloroformate. The company asserts that it accounts for the entire domestic production of this critical chemical intermediate.
In its complaint, Paushak has presented evidence claiming that surging imports from China have led to "material injury" to domestic producers. The company specifically highlighted issues of price suppression and a severe erosion of profitability within the local market.
Examining Dumping and Potential Duties
The DGTR's investigation will meticulously examine two core allegations. First, whether ethyl chloroformate is indeed being dumped into the Indian market—that is, sold at prices below its normal value in China. Second, whether the imposition of anti-dumping duties is necessary to counteract the alleged injury suffered by the domestic industry.
A preliminary assessment by the trade body has indicated that the alleged dumping margin appears to be above the de minimis threshold. This finding suggests there may have been substantial price undercutting by Chinese exporters, a critical factor in such trade remedy cases.
Strategic Chemical with Broad Sectoral Impact
Ethyl chloroformate is an essential organic chemical intermediate, widely utilized in the manufacturing processes of the pharmaceutical and agrochemical sectors. Its pivotal role means that any eventual decision to impose anti-dumping duties could have far-reaching consequences.
While protective duties would shield domestic producers like Paushak, they could simultaneously increase input costs for downstream Indian drugmakers and agrochemical companies, potentially affecting final product pricing.
Investigation Timeline and Parallel Probe
The investigation will cover imports from October 2024 to September 2025. During this period, the DGTR will collect and assess submissions, evidence, and arguments from all interested parties, including Chinese exporters, Indian importers, and domestic industry representatives, before making a final recommendation to the central government.
In a related development underscoring heightened trade scrutiny, the DGTR has also initiated a separate anti-dumping investigation into imports of hexamine, another chemical intermediate. This probe targets imports originating from or exported by China, Russia, and the United Arab Emirates.
Part of Broader Trade Policy Focus
These investigations are not isolated incidents. They reflect India's broader, ongoing strategy to address the influx of low-cost imports, particularly from China, which domestic manufacturers claim are undermining local production. This policy was evident recently when India imposed tariffs on certain steel imports to curb cheap Chinese products.
Taken together, the ethyl chloroformate and hexamine probes signal a more assertive regulatory stance on chemical imports. This approach balances the protection of domestic manufacturing with careful consideration of the input cost implications for vital downstream industries like pharmaceuticals and agrochemicals, shaping both industrial policy and trade dynamics.
